Live feed
·
INSIDERFilingvia Quantisnow
Lumos Pharma Inc. logo

Lumos Pharma (LUMO) CFO Lawley gave up 229 shares at $1.79 to cover taxes or an exercise price

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Lori D Lawley (Chief Financial Officer at Lumos Pharma Inc., LUMO) reported that they gave up 229 shares at $1.79 to cover taxes or an exercise price on Aug 1, 2024. After these transactions the filing shows 12,284 shares held directly.

Reporting person
Lawley Lori D
Role
Chief Financial Officer
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Aug 1, 2024Shares withheld for taxes or exercise price (F)Common Stock1, 2, 3, ...-229$1.79$41012,284 direct

Holdings before and after

  • Common Stock: 12,513 to 12,284 direct

Footnotes from the filing

  1. 1. Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 937 previously reported restricted stock units ( RSUs ) granted to the Reporting Person.
  2. 2. Includes 218 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person on February 1, 2025, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
  3. 3. Includes 938 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person on August 1, 2025, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
  4. 4. Includes 500 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on February 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
  5. 5. Includes 750 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
  6. 6. Includes 1,000 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments beginning on April 1, 2025, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.

Transaction codes in this filing

Shares withheld for taxes or exercise price:
Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.

FAQ

What did Lawley report in this LUMO Form 4?

Lori D Lawley (Chief Financial Officer at Lumos Pharma Inc., LUMO) reported that they gave up 229 shares at $1.79 to cover taxes or an exercise price on Aug 1, 2024. After these transactions the filing shows 12,284 shares held directly.

How many LUMO shares does Lawley hold after this filing?

The filing shows 12,284 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code F mean on an SEC Form 4?

Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.

Historical context for LUMO

Earlier insider filings at LUMO

Quantisnow market dataNASDAQ
Lumos Pharma Inc. logo
LUMO
Lumos Pharma Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2011
Get push alerts for LUMO

Follow LUMO and get a push notification the moment its next story breaks.

Full LUMO profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LUMO (Lumos Pharma Inc.) and more on Quantisnow.